Our main focus is on reducing the population harms caused by nicotine and tobacco products. Our research spans clinical trials of new smoking cessation and harm reduction interventions, policy analyses and evaluation, epidemiology and qualitative research. Our research includes strategies aimed at the whole population and also targeted interventions for priority populations, particularly people living with medical conditions (e.g. mental health disorders, substance use disorders, HIV).

Current projects

  • A pragmatic randomised controlled trial of nicotine vaporisers for smoking cessation among priority populations with co-morbidities.
  • Research to develop an audio-visual health education resource to assist priority populations to quit smoking.
  • A longitudinal study of smokers, former smokers and vapers in Australia, Canada, USA and UK to evaluate the impact of tobacco control policy on smoking and vaping (The International Tobacco and Vaping Policy Study). 
  • Implementation Science study of embedding smoking cessation support and health promotion activities into community organisations across a region (the 10,000 Lives Project).
  • Analysis of Australian and international health policy regarding tobacco harm reduction strategies.
  • Research on ways to improve public understandings of the differential harms of the continuum of nicotine and tobacco products.
  • Using wastewater analysis to monitor tobacco and nicotine product use in the community in association with the Queensland Alliance for Environmental Health Sciences.
  • The association of smoking compared to vaping on clinical periodontal parameters, inflammatory biomarkers and biomarkers of exposure to metals and trace elements.
  • Effects of vaporised nicotine product aerosol exposure on primary human bronchial epithelial cells compared to cigarette smoke and control air
  • Health practitioner views and practices regarding vaping as a harm reduction strategy for smokers.
  • Evaluation of implementation of smokefree policy into university settings in Queensland.
  • The relationship between tobacco and cannabis use.

We have received funding from NHMRC, ARC, VicHealth, HIV Foundation Queensland

PhD students